Raymond James Financial
THTX

Raymond James Financial’s Theratechnologies THTX Stock Holding History

Raymond James Financial’s Portfolio THTX Stock Details THTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-3,592
Closed -$8.48K – 6608
2025
Q2 		$8.48K Buy
+3,592
New +$8.8K ﹤0.01% 5986
2025
Q1 		– Sell
-15,022
Closed -$27.2K – 4949
2024
Q4 		$27.2K Buy
+15,022
New +$20.4K ﹤0.01% 4688

Other funds holding THTX

JC
JBF Capital Aspen, Colorado $676M AUM 24.74% 1-Year Est. Return
Skandinaviska Enskilda Banken (SEB)
Skandinaviska Enskilda Banken (SEB) Stockholm, Sweden $4.34B AUM 19.31% 1-Year Est. Return
TC
Trium Capital London, United Kingdom $163M AUM 45.8% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
CWP
Cyndeo Wealth Partners St. Petersburg, Florida $1.9B AUM 24.89% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
GIP
Greatmark Investment Partners Columbus, Georgia $854M AUM 15.72% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return
TWC
TD Waterhouse Canada Toronto, Ontario, Canada $33.7B AUM 35.49% 1-Year Est. Return
GRP
Global Retirement Partners San Rafael, California $5.64B AUM

Raymond James Financial's THTX Position: Q3 2025 in Review

Raymond James Financial sold out of Theratechnologies (THTX) in Q3 2025, closing a stake of 3,592 shares — an estimated $8.48K sold.

Raymond James Financial first reported a position in THTX in Q4 2024 and held it in 2 quarters. The position peaked at $27.2K in Q4 2024. 10 funds tracked by Wall St. Rank hold THTX as of Q3 2025.

  • Raymond James Financial reported no remaining Theratechnologies position as of Q3 2025 after selling out during the quarter.
  • Raymond James Financial sold 3,592 Theratechnologies shares in Q3 2025, an estimated $8.48K.
  • Raymond James Financial first reported a position in Theratechnologies in Q4 2024 and held it in 2 quarters.
  • Raymond James Financial's Theratechnologies position peaked at $27.2K in Q4 2024.
  • 10 funds tracked by Wall St. Rank held Theratechnologies as of Q3 2025.

Based on Raymond James Financial's 13F filing for Q3 2025, filed 14 Nov 2025.